The study reveals that while approximately 904 children per million developed long COVID symptoms after their initial COVID-19 infection, this incidence more than doubled to around 1,884 children per million following reinfection. Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), manifests as a constellation of symptoms persisting beyond the acute phase of infection, often debilitating and challenging to treat. The mechanisms underlying increased susceptibility to long COVID after reinfection remain an active area of investigation. This nuanced understanding could pave the way for novel therapeutic targets aimed at modulating immune response or viral persistence to reduce long COVID incidence. In conclusion, this landmark study elucidates the compounded risk long COVID poses to children upon reinfection, particularly amidst the highly transmissible Omicron waves.